The purpose of this research study is to see if using a combination of medications will work better than placebo to treat methamphetamine use disorder. The two medications to be tested are bupropion (also called Wellbutrin) and naltrexone (also called Vivitrol).
The RECLAIM study is a placebo-controlled trial designed to evaluate the efficacy and safety of Pemvidutide, a novel GLP-1/glucagon receptor dual agonist, in adults with AUD who are also overweight or obese.